Get your full text copy in PDF

A case report of osteonecrosis of jaw while receiving chemotherapy

Jawaid Younus, Mary Eisenhauer, Lyn Kligman

Am J Case Rep 2008; 9:428-430

ID: 869460

Background: Bisphosphonates are indicated in patients with hypercalcemia of malignancy or with skeletal metastases. Recent reports have described the development of osteonecrosis of the jaw (ONJ) related to bisphosphonate therapy. Other risk factors for ONJ include radiation therapy and oral procedures. These patients pose a difficult problem for clinicians, both in terms of diagnosis as well as management.
Case Report: We describe in this case report a patient with metastatic breast cancer who developed ONJ while treated with chemotherapy and bisphosphonates but without other risk factors.
Conclusions: With recent reports of ONJ in the literature it is important to keep this disease in mind particularly among patients treated with bisphosphonates and those with concomitant mucositis.

Keywords: osteonecrosis of the jaw, bisphosphonates, breast cancer metastatic

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.

I agree